Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia
Studies on the outcome of adolescents and young adults (AYAs) with acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL) are limited. We compared outcomes of AYAs (age, 19-30 years) and pediatric (age, 0-18 years) patients with AML and APL using the Surveillance, Epidemiology, and End Results-18 registry. AYA patients with AML have worse early mortality and overall survival compared with pediatric patients with AML, whereas AYA and pediatric patients with APL have similar outcomes.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Syed Sameer Nasir, Smith Giri, Sara Nunnery, Mike G. Martin Tags: Original Study Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Epidemiology | Hematology | Leukemia | Lymphoma | Myeloma | Pediatrics | Study